Browse by Section 100 Item List
Efficient Funding of Chemotherapy – Related Benefits
Further information can be found in the Explanatory Notes.
- Legend
- MPMedical Practitioner
| Prescriber code | Item code | Name, manner of administration and form & strength | Max qty packs |
Max qty units |
No. of repeats |
|---|---|---|---|---|---|
| MP | 2550F | APREPITANTaprepitant 165 mg capsule, 1 | 1 | 1 | 5 |
| MP | 14226R | ATEZOLIZUMABatezolizumab 1.875 g/15 mL injection, 15 mL vial | 1 | 1 | 4 |
| MP | 14249Y | ATEZOLIZUMABatezolizumab 1.875 g/15 mL injection, 15 mL vial | 1 | 1 | 7 |
| MP | 14250B | ATEZOLIZUMABatezolizumab 1.875 g/15 mL injection, 15 mL vial | 1 | 1 | 5 |
| MP | 14255G | ATEZOLIZUMABatezolizumab 1.875 g/15 mL injection, 15 mL vial | 1 | 1 | 7 |
| MP | 14268Y | ATEZOLIZUMABatezolizumab 1.875 g/15 mL injection, 15 mL vial | 1 | 1 | 7 |
| MP | 14277K | ATEZOLIZUMABatezolizumab 1.875 g/15 mL injection, 15 mL vial | 1 | 1 | 3 |
| MP | 14289C | ATEZOLIZUMABatezolizumab 1.875 g/15 mL injection, 15 mL vial | 1 | 1 | 3 |
| MP | 14298M | ATEZOLIZUMABatezolizumab 1.875 g/15 mL injection, 15 mL vial | 1 | 1 | 5 |
| MP | 14575D | ATEZOLIZUMABatezolizumab 1.875 g/15 mL injection, 15 mL vial | 1 | 1 | 8 |
| MP | 12682L | DARATUMUMABdaratumumab 1.8 g/15 mL injection, 15 mL vial | 1 | 1 | 5 |
| MP | 12745T | DARATUMUMABdaratumumab 1.8 g/15 mL injection, 15 mL vial | 1 | 1 | 4 |
| MP | 12746W | DARATUMUMABdaratumumab 1.8 g/15 mL injection, 15 mL vial | 1 | 1 | 8 |
| MP | 13201T | DARATUMUMABdaratumumab 1.8 g/15 mL injection, 15 mL vial | 1 | 1 | 15 |
| MP | 13203X | DARATUMUMABdaratumumab 1.8 g/15 mL injection, 15 mL vial | 1 | 1 | 5 |
| MP | 1899Y | FOLINIC ACIDfolinic acid 50 mg/5 mL injection, 10 x 5 mL ampoules | 1 | 10 | 2 |
| MP | 5904R | FOLINIC ACIDfolinic acid 15 mg tablet, 10 | 1 | 10 | 0 |
| MP | 11103J | FOSAPREPITANTfosaprepitant 150 mg injection, 1 vial | 1 | 1 | 5 |
| MP | 13650K | FOSNETUPITANT + PALONOSETRONfosnetupitant 235 mg + palonosetron 250 microgram injection, 1 vial | 1 | 1 | 5 |
| MP | 5899L | GRANISETRONgranisetron 3 mg/3 mL injection, 3 mL ampoule | 1 | 1 | 0 |
| MP | 5898K | GRANISETRONgranisetron 2 mg tablet, 1 | 2 | 2 | 0 |
| MP | 5961R | MESNAmesna 1 g/10 mL injection, 15 x 10 mL ampoules | 1 | 15 | 5 |
| MP | 5960Q | MESNAmesna 400 mg/4 mL injection, 15 x 4 mL ampoules | 1 | 15 | 5 |
| MP | 12925G | MYCOBACTERIUM BOVIS BCG DANISH STRAINMycobacterium bovis BCG Danish strain 30 mg injection, 4 vials | 3 | 3 | 1 |
| MP | 5902P | MYCOBACTERIUM BOVIS BCG TICE STRAINMycobacterium bovis BCG Tice strain 500 million CFU injection, 3 vials | 1 | 3 | 1 |
| MP | 10714X | NETUPITANT + PALONOSETRONnetupitant 300 mg + palonosetron 500 microgram capsule, 1 | 1 | 1 | 5 |
| MP | 5858H | ONDANSETRONondansetron 8 mg orally disintegrating tablet, 4 | 1 | 4 | 0 |
| MP | 5967C | ONDANSETRONondansetron 4 mg tablet, 4 | 1 | 4 | 0 |
| MP | 5968D | ONDANSETRONondansetron 8 mg tablet, 4 | 1 | 4 | 0 |
| MP | 5848T | ONDANSETRONondansetron 4 mg/5 mL oral liquid, 50 mL | 1 | 1 | 0 |
| MP | 5857G | ONDANSETRONondansetron 4 mg orally disintegrating tablet, 4 | 1 | 4 | 0 |
| MP | 5853C | PALONOSETRONpalonosetron 250 microgram/5 mL injection, 5 mL vial | 1 | 1 | 0 |
| MP | 10743K | TRASTUZUMABtrastuzumab 600 mg/5 mL injection, 5 mL vial | 1 | 1 | 3 |
| MP | 10811B | TRASTUZUMABtrastuzumab 600 mg/5 mL injection, 5 mL vial | 1 | 1 | 0 |
| MP | 10817H | TRASTUZUMABtrastuzumab 600 mg/5 mL injection, 5 mL vial | 1 | 1 | 3 |
